Business · 31/05/2019Updated: 10/17/2026 · 1 min read

FDA Hosts Public Workshop to Improve Risk-Based Monitoring in Clinical Investigations

The FDA is hosting a public workshop to gather stakeholder input on improving the implementation of risk-based monitoring approaches in clinical investigations, led by Duke University's Robert J. Margolis, MD, and supported by a cooperative agreement with the FDA.